20-F: Genenta Science S.p.A. Details Securities Registered Under Exchange Act in 20-F Filing

Genenta Science S.p.A. outlines its registered securities, including Ordinary Shares and American Depositary Shares (ADSs), as of December 31, 2024, in its latest 20-F filing.

Summary

• Genenta Science S.p.A. had Ordinary Shares and American Depositary Shares (ADSs) registered under Section 12(b) of the Exchange Act as of December 31, 2024.
• The company's issued share capital consisted of 18,273,490 Ordinary Shares as of December 31, 2024.
• Registered holders of Ordinary Shares are generally entitled to one vote per share, with a loyalty share program potentially granting up to ten votes per share for long-term shareholders.
• ADS holders are not entitled to additional voting rights under the loyalty share program.
• The Bank of New York Mellon acts as the depositary for Genenta's ADSs.
• ADS holders may instruct the depositary how to vote the Ordinary Shares their ADSs represent.
• The depositary has agreed to pay or distribute to ADS holders the cash dividends or other distributions it receives on shares or other deposited securities, upon payment or deduction of its fees and expenses.
• The deposit agreement expressly limits the obligations and liabilities of both the company and the depositary.
• The depositary will initiate termination of the deposit agreement under certain conditions, including at the company's instruction or if the ADSs are delisted.
• ADS holders can surrender their ADSs and receive delivery of deposited securities, subject to the depositary's fees and expenses and any applicable taxes or charges.

Sentiment

Score: 6

Explanation: The document is neutral in sentiment, providing factual information about the company's registered securities and related agreements. It does not express any positive or negative opinions about the company's performance or prospects.

Positives

• The loyalty share program incentivizes long-term investment in the company.
• ADS holders are entitled to receive payments in respect of dividends on the underlying shares through BNY, as Depositary, in accordance with the Deposit Agreement.
• The company's Ordinary Shares are not represented by share certificates (certificati azionari) as they are dematerialised (azioni dematerializzate).
• There are no limitations on the right to own or vote our Ordinary Shares, which applies to non-Italian residents and foreign residents.

Negatives

• ADS holders are not eligible for the loyalty share program's additional voting rights.
• The deposit agreement limits the obligations and liabilities of both the company and the depositary.
• The depositary may terminate the deposit agreement under specific circumstances, including delisting of ADSs.
• ADS holders can surrender their ADSs for the underlying deposited securities, subject to fees and taxes.

Risks

• The deposit agreement limits the obligations and liabilities of both the company and the depositary.
• The depositary may terminate the deposit agreement under specific circumstances, including delisting of ADSs.
• ADS holders can surrender their ADSs for the underlying deposited securities, subject to fees and taxes.

Future Outlook

The document outlines the structure and rights associated with Genenta Science's registered securities but does not provide specific forward-looking statements regarding the company's future financial performance or business prospects.

Industry Context

This announcement is a standard regulatory filing detailing the structure of the company's registered securities. It does not directly relate to specific industry trends or competitive positioning but provides essential information for investors.

Comparison to Industry Standards

• The document describes standard features of publicly traded companies with ADSs, such as voting rights, dividend distribution processes, and depositary agreements.
• Comparable companies like BioNTech (BNTX) and Moderna (MRNA) also have similar structures for their ADSs, including agreements with depositary banks and processes for shareholder voting and dividend distribution.
• The loyalty share program is less common but is used by some European companies to incentivize long-term investment, such as Stellantis (STLA).

Stakeholder Impact

• Shareholders: Provides information on share structure, voting rights, and dividend distribution.
• ADS Holders: Details the rights and limitations specific to ADS holders.
• Potential Investors: Offers insights into the company's capital structure and regulatory framework.

Key Dates

Keywords

Ordinary Shares, American Depositary Shares, ADSs, Share Capital, Voting Rights, Dividends, Genenta Science, Depositary, Deposit Agreement, Securities